Detalhe da pesquisa
1.
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Invest New Drugs
; 37(3): 548-558, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028663
2.
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.
Cancer Immunol Immunother
; 66(10): 1295-1306, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28555258
3.
The significance of serum immunoglobulin paraprotein in diffuse large B-cell lymphoma.
Br J Haematol
; 182(5): 741-742, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832947
4.
The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia.
Ann Hematol
; 94(4): 681-2, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25193355
5.
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
Clin Cancer Res
; 25(17): 5231-5241, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171545
6.
Hepatitis B virus infection.
N Engl J Med
; 360(3): 304-5; author reply 305-6, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19148965
7.
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study.
Leukemia
; 36(11): 2719-2723, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127510
8.
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.
Leuk Res
; 104: 106552, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689920
9.
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients.
Oncoimmunology
; 4(3): e990773, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25949906
10.
Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients.
Am J Clin Pathol
; 122(2): 298-306, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15323147
11.
Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?
Ann Hematol
; 88(3): 283-4, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18807036
12.
Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.
PLoS One
; 9(4): e93903, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24705344
13.
Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma.
Br J Haematol
; 141(2): 265-8, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18353165
14.
Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
Cancer Chemother Pharmacol
; 72(1): 13-33, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23475105
15.
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.
Leuk Lymphoma
; 53(2): 263-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21846184
16.
'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.
World J Gastrointest Pharmacol Ther
; 3(2): 21-8, 2012 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22577616
17.
HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Dig Liver Dis
; 43(2): 139-42, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20554488
18.
Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23+/MLL+ translocation in leukaemia.
Br J Haematol
; 121(6): 953-5, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12786810